探讨阿托伐他汀钙联合硝苯地平缓释片治疗高血压的临床疗效

赵燕

摘要：目的：观察对高血压患者予以硝苯地平缓释片阿托伐他汀钙的价值。方法：观察对象为就诊于我院的78例高血压症患者，因治疗药物差异性实行分组，40例的治疗药物为硝苯地平缓释片阿托伐他汀钙片，纳入试验组，38例的治疗药物为硝苯地平缓释片，纳入对照组，比较和观察治疗效果。结果：比较对照组临床疗效，试验组总有效率显著提升，显著差异，P<0.05。结论：对高血压症患者予以硝苯地平缓释片阿托伐他汀钙效果良好，建议推广。

关键词：高血压;冠心病;硝苯地平缓释片阿托伐他汀;治疗总有效率

Objective： To observe the value of atorvastatin calcium in nifedipine sustained release tablets in patients with hypertension. Methods： 78 patients with hypertension were treated in our hospital. 40 patients were treated with nifedipine sustained-release tablet atorvastatin calcium tablet， which was included in the experimental group， 38 cases were nifedipine sustained-release tablets， and included in the control group， and the therapeutic effects were compared and observed. Results： compared with the control group， the total effective rate of the experimental group was significantly improved， the difference was significant （P < 0.05）. Conclusion： the effect of atorvastatin calcium on nifedipine sustained release tablets is good in hypertension patients， and it is suggested to be popularized.

Key words： hypertension; Coronary heart disease; Atorvastatin was used as nifedipine sustained release tablets; Total effective treatment

在临床上高血压作为慢性疾病之一较为常见，以动脉压提升异常为病理特征，血压控制不佳，极易导致冠脉狭窄，多数患者会合并冠心病，使得病情加重，对患者生命安全造成严重威胁。本次研究对其应用价值进行观察，结果如下。

1资料与方法

1.1一般资料

观察对象为就诊于我院的78例高血压症患者（2020.2-2021.2），因治疗药物差异性实行分组，40例的治疗药物为硝苯地平缓释片阿托伐他汀钙片，纳入试验组，资料：（57.15±1.45）岁为本组年龄均值（38-80岁），22例、18例为本组患者男女数量，（6.10±0.55）年为本组病程均值（1-13年）;38例的治疗药物为硝苯地平缓释片，纳入对照组，资料：（57.30±1.40）岁为本组年龄均值（40-80岁），20例、18例为本组患者男女数量，（6.13±0.56）年为本组病程均值（2-12年），资料实行统计学计算，差异性无，P>0.05，研究比較性有效。

1.2方法

对照组中对象除常规治疗外亦采用同时增加硝苯地平缓释片，产品选自拜耳医药保健有限公司，获得国药准字号J20130115可经食药总局查询，药剂规格为30mg。……